// App-Quantinova.ai

: Endothelial-Targeted CD39 Ameliorates Pulmonary Hypertension in a Murine Model of Endothelial Toxin Administration

Researchers

Presenter

  • Abbey Willcox

Principal Investigators

  • Xiaowei Wang

  • Carly Selan

  • Natsha Lee

  • Ilaria Calvello

  • Viktoria Bongcaron

  • Aidan Walsh

  • Yuyang Song

  • Simon C. Robson

  • Karlheinz Peter

  • Maithili Sashindranath

  • Harshal Nandurkar

Medical Centers

  • Australian Centre of Blood Diseases, Monash University and Alfred Health, Melbourne, Australia

  • Baker Heart and Diabetes Institute, Melbourne, AUSTRALIA

  • Baker Institute, Melbourne, Australia

  • Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia

  • Alfred Health and Monash University, Melbourne, Australia

  • MONASH UNIVERSITY, Melbourne, Australia

  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Locations

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Vascular cell adhesion molecule 1

Drug/Treatment

  • Monocrotaline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved